PSA quick test in capillary blood

Anticancer Research

Volumn 25, Issue 3 A, 2005, Pages 1659-1662

  Loertzer, Hagen ^a   Fischer, K ^a   Fornara, P ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Capillary blood; Prostate cancer; PSA; Test strip

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BLOOD CHEMISTRY; CANCER SCREENING; CAPILLARY BLOOD; CLINICAL TRIAL; CONFERENCE PAPER; COST; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PSA QUICK TEST; QUANTITATIVE ASSAY; TEST STRIP;

CAPILLARIES; HUMANS; IMMUNOASSAY; MALE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 21244476422     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Becker: Epidemiologie. In: Geriatische Onkologie. (Höffken K, Kolb G, Wedding U, eds). Springer, Berlin Heidelberg New York Tokio, pp. 1-28, 2002.
2. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
3. Oesterling JE: Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
4. Labrie F, Dupont A, Suburu R Cusan L, Tremblay M, Gomez JL and Emond J: Prostate-specific antigen as a pre-screening test for prostate cancer. J Urol 147: 848-851, 1992.
5. Polascik TJ, Oesterling JE and Partin AW: Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J Urol 162: 293-306, 1999.
6. Mikolajczyk SD, Marks LS, Partin AW and Rittenhouse HG: Free prostate-specific antigen in serum is becoming more complex. Urol 59: 797-802, 2002.
7. Jung K, Zachow J, Lein M, Brux B, Sinha P, Lenk S, Schnorr D and Loening SA: Rapid detection of elevated prostate-specific antigen in blood: performance of various membrane strip tests. Urology 55: 155-160, 1999.
8. Lein M, Jung K, Schnorr D, Henke W and Loening SA: Strip test for the quick detection of increased concentrations of prostate-specific antigen in blood. Eur J Clin Chem Clin Biochem 34: 511-514, 1996.
9. Madersbacher S, Mian C, Maier U and Simak R: Validation of a 10-minute dipstick test for serum prostate-specific antigen. Eur Urol 30: 446-450, 1996.
10. Thomas L: Laborbefund. In: Labor und Diagnose. (Thomas L, ed). 4th ed. TH Books, pp. 1491-1506, 2000.
11. Lein M and Semjonow A: PSA-Streifentestung - Einschätzung und Empfehlung. In: PSA: Der Weg zum Befund. (Fornara P, Semjonow P, eds). Zuckschwerdt-Verlag, pp. 52-57, 2002.
12. Fischer K and Fornara P: Analysegeräte. In: PSA: Der Weg zum Befund. (Fornara P, Semjonow P, eds). Zuckschwerdt-Verlag, pp. 42-51, 2002.
13. Sachs L: Angewandte Statistik. Berlin, Heidelberg, New York: Springer, 1973.
14. Berg W, Eschholz G, Linder C, Link St and Schubert J: Einfacher Schnell- und Suchtest im Vollblut - Voraussetzung für ein Frü herkennungsprogramm des Prostatakarzinoms. Akt Urol 29: 120-123, 1998.
15. Kleer E, Larson-Keller JJ, Zincke H and Oesterling JE: Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy: influence of clinical stage and tumor grade. Urology 41: 207-216, 1993.
16. Brawer MK: Prostate-specific antigen: current status. CA Cancer J Clin 49: 264-281, 1999.
17. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsch PC, Scardino PT, Paul HL, Subong ENP, Parson RE, Gasior GH, Loveland KG and Southwick PC: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279: 1542-1547, 1998.
18. Andriole GL and Catalona WJ: Using PSA to screen for prostate cancer: The Washington University experience. Urol Clin North Am 20: 647-651, 1993.
19. Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT and Southwick PC: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
20. Feil G: Qualitätskontrolle. In: PSA: Der Weg zum Befund. (Fornara P, Semjonow P, eds). Zuckschwerdt-Verlag, pp. 73-82, 2002.
21. Ciatto S, Bonardi R, Lombardi C, Zappa M, Gervasi G and Cappelli G: Analysis of PSA velocity in 1666 healthy subjects undergoing total PSA determination at two consecutive screening rounds. Int J Biol Markers 17: 79-83, 2002.
22. Ito K, Yamamoto T, Ohi M, Fukabori Y, Kurokawa K, Suzuki K and Yamanaka H: Usefulness of prostate-specific antigen velocity in screening for prostate cancer. Int J Urol 9: 316-321, 2002.
23. Loertzer H, Fischer K, Wagner S and Fornara P: PSA-Teststreifen - Eine sichere Diagnosestellung in Sekundenschnelle? Extracta Urologica 5: 44, 2003
24. Smith DS, Catalona WJ and Herschman DJ: Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA 276: 1309-1315, 1996.
25. Carter HB, Epstein JI and Chan DW: Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer. JAMA 277: 1456-1460, 1997.
26. Leewansangtong S, Crawford ED, Gordon SG, Serdar G, Holthaus K, Baier M, Stone NN, Eisenberger M, Staggers F and McLoed D: Longitudinal follow up for Prostate Cancer Awareness Week (PCAW): screening intervals. J Urol 159: 177-180, 1998.
27. Brawer MK: Prostate Specific Antigen. 1st ed. Marcel Dekker Inc., pp. 144-154, 2001.